Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01899950 · ClinicalTrials.gov registry record
Longitudinal Study of Cognition With Niemann-Pick Disease, Type C
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 70
- Enrollment target
NCT01899950: Completed study, sponsored by Mayo Clinic.
NCT01899950 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01899950 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
Niemann-Pick Disease, Type C (NPC) is a rare neurodegenerative disorder with a wide clinical spectrum and variable age of onset. Classically, children with NPC demonstrate neurological dysfunction with cerebellar ataxia (an inability to coordinate balance, gait, extremity and eye movements), dysarthria (difficulty speaking), seizures, vertical gaze palsy (ability to move eyes in the same direction) motor impairment, dysphagia (trouble swallowing), psychotic episodes, and progressive dementia. There is no curative treatment for NPC and it is a lethal disorder. The purpose of this protocol is to obtain both baseline and rate of progression data on a clinical and biochemical markers that may later be used as outcome measures in a clinical trial. Specifically, this study will examine and characterize the longitudinal progression of neurocognitive symptoms of NPC with the goal of identifying early markers of disease progression that may be utilized in later trials to evaluate treatment efficacy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01899950
The ClinicalTrials.gov registry entry for NCT01899950 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01899950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01899950 about?
NCT01899950 is a clinical study titled "Longitudinal Study of Cognition With Niemann-Pick Disease, Type C". Niemann-Pick Disease, Type C (NPC) is a rare neurodegenerative disorder with a wide clinical spectrum and variable age of onset. Classically, children with NPC demonstrate neurological dysfunction with cerebellar ataxia (an inability to coordinate balance, gait, extremity and eye movements), dysarth...
What is the current status of trial NCT01899950?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2011-03. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01899950?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.